Home
>
National Drug Code (NDC)
>
Teniposide
Teniposide - 44567-507-01 - (Teniposide)
Drug Information of Teniposide
| Product NDC: | 44567-507 |
| Proprietary Name: | Teniposide |
| Non Proprietary Name: | Teniposide |
| Active Ingredient(s): | 10 mg/mL & nbsp; Teniposide |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Teniposide
| Product NDC: | 44567-507 |
| Labeler Name: | WG Critical Care, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020119 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130430 |
Package Information of Teniposide
| Package NDC: | 44567-507-01 |
| Package Description: | 1 AMPULE in 1 CARTON (44567-507-01) > 5 mL in 1 AMPULE |
NDC Information of Teniposide
| NDC Code | 44567-507-01 |
| Proprietary Name | Teniposide |
| Package Description | 1 AMPULE in 1 CARTON (44567-507-01) > 5 mL in 1 AMPULE |
| Product NDC | 44567-507 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Teniposide |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20130430 |
| Marketing Category Name | NDA |
| Labeler Name | WG Critical Care, LLC |
| Substance Name | TENIPOSIDE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
